862 studies found for:    Open Studies | "Blood Coagulation Disorders"
Show Display Options
Rank Status Study
21 Not yet recruiting Pilot Study to Compare Fresh Frozen Plasma With 24-Hour Plasma in Babies Up to Age Six Months
Condition: Blood Coagulation Disorders
Intervention: Biological: Plasma
22 Recruiting Does Plasma Reduce Bleeding in Patients Undergoing Invasive Procedures
Conditions: Blood Coagulation Disorders;   Hemorrhage
Intervention: Biological: Fresh frozen plasma transfusion
23 Not yet recruiting Transfusion of Plasma Prior to Invasive Procedures Pilot Trial (TOPPIT)
Condition: Blood Coagulation Disorders
Intervention: Biological: Frozen plasma
24 Recruiting ROTEM® Sigma Performance Evaluation - Method Comparison With Predicate Device and Reference Intervals
Condition: Blood Coagulation Disorders
Intervention: Device: ROTEM sigma
25 Recruiting A Prospective Study of Airless Tubing in an Inpatient Acute Hemodialysis Unit in Hospitalized Patients
Conditions: End Stage Renal Failure on Dialysis;   Complication of Dialysis;   Blood Coagulation Disorders
Intervention:
26 Recruiting Left Atrial Appendage Occlusion vs. Usual Care in Patients With Atrial Fibrillation and Severe Chronic Kidney Disease
Conditions: Blood Coagulation Disorders;   Atrial Fibrillation;   Thrombosis of Left Atrial Appendage;   Chronic Kidney Disease Stage 4;   Chronic Kidney Disease Stage 5
Intervention: Device: Left atrial appendage occlusion
27 Recruiting The 1200 Patients Project: Studying the Implementation of Clinical Pharmacogenomic Testing
Conditions: Patients Undergoing Routine Health Care;   Heart Diseases;   Inflammatory Bowel Diseases;   Autoimmune Disease;   Inflammatory Disease;   Blood Coagulation Disorders;   Hepatitis C;   Non-Metastatic Neoplasm
Intervention:
28 Unknown  The Effect of a Levonorgestrel-releasing Intrauterine Device (IUD) Versus a Copper Containing IUD on Risk of Blood Clots
Condition: Blood Coagulation Disorders
Interventions: Device: Levonorgestrel-containing IUD (Mirena®);   Device: Copper-containing IUD (Paraguard®)
29 Unknown  "Salvage Use" of Recombinant Factor VIIa After Inadequate Haemostasis in Complex Cardiac Surgery
Conditions: Myocardial Ischemia;   Blood Coagulation Disorders;   Coronary Artery Disease;   Heart Valve Diseases
Intervention: Drug: Recombinant Activated Factor VII
30 Not yet recruiting Human Fibrinogen Concentrate in Pediatric Cardiac Surgery
Conditions: Hypofibrinogenemia;   Afibrinogenemia;   Bleeding Disorders
Interventions: Drug: RiaStAP;   Drug: Saline
31 Recruiting Motor Proficiency of People With Bleeding Disorders Using the BOT-2 (TM)
Condition: Hemophilia
Intervention:
32 Recruiting Ex Vivo Laboratory Assays Application for Therapy Tailoring in Patients With Severe Bleeding Disorders
Condition: Severe Hemophilia
Intervention:
33 Recruiting Trial Investigating Safety, Pharmacokinetics and Pharmacodynamics of Concizumab Administered Subcutaneously to Haemophilia A Subjects
Conditions: Congenital Bleeding Disorder;   Haemophilia A
Interventions: Drug: Concizumab;   Drug: placebo
34 Recruiting To Investigate Safety and Efficacy of NovoEight® (rFVIII) During Long-term Treatment of Haemophilia A in Japan
Conditions: Congenital Bleeding Disorder;   Haemophilia A
Intervention: Drug: turoctocog alfa
35 Recruiting Safety and Efficacy of Nonacog Beta Pegol (N9-GP) in Previously Untreated Patients With Haemophilia B
Conditions: Congenital Bleeding Disorder;   Haemophilia B
Intervention: Drug: nonacog beta pegol
36 Recruiting Safety and Efficacy of Turoctocog Alfa in Prevention and Treatment of Bleeds in Previously Untreated Children With Haemophilia A
Conditions: Congenital Bleeding Disorder;   Haemophilia A
Intervention: Drug: turoctocog alfa
37 Recruiting Evaluating the Haemostatic Effect of NNC 0129-0000-1003 During Surgical Procedures in Subjects With Haemophilia A
Conditions: Congenital Bleeding Disorder;   Haemophilia A
Intervention: Drug: turoctocog alfa pegol
38 Recruiting Swiss Hemophilia Registry
Condition: Hemophilia and Other Severe Bleeding Disorders
Intervention: Other: Registry
39 Recruiting Safety Study of Spray-Dried Solvent/Detergent-Treated Plasma for Infusion in Healthy Volunteers
Condition: Coagulation Defects
Interventions: Biological: Spray-dried S/D-treated Plasma;   Drug: Spray-dried S/D-treated plasma
40 Recruiting Post-Marketing Requirement to Evaluate the Safety of Octaplas™ Versus Plasma in Patients Undergoing Orthotopic Liver Transplantation With Special Emphasis on Hyperfibrinolysis.
Conditions: Coagulopathy;   Endstage Liver Disease
Interventions: Biological: Octaplas™;   Biological: Plasma

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years